Karyopharm Grants 1,450 RSUs to Newly Hired Employees Under Inducement Plan
Reuters
Mar 03
Karyopharm Grants 1,450 RSUs to Newly Hired Employees Under Inducement Plan
Karyopharm Therapeutics Inc. granted an aggregate of 1,450 restricted stock units to two newly hired employees under its 2022 Inducement Stock Incentive Plan, with awards dated Feb. 28, 2026. The RSUs vest over three years, with one-third vesting on each of the first three anniversaries of the grant date, subject to continued service.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Karyopharm Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202603021605PR_NEWS_USPR_____NE95077) on March 02, 2026, and is solely responsible for the information contained therein.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.